Unique CGM integration Pacific Diabetes Technologies offers a hollow glucose sensor that integrates continuous glucose monitoring with insulin infusion at a single site using one needle per week, presenting a strong value proposition for patients and payers seeking to reduce device complexity and needle burden.

Pediatric and reluctant users The devices are designed to reduce needle trauma and adhesive irritation, improving adherence among pediatric patients and reluctant adult users, signaling opportunity to target clinics and programs focusing on pediatric diabetes and patient onboarding.

Single-site efficiency Product lines include a needle-free CGM Injection Port, CGM Infusion Set, and Infusion Cannula for tubeless patch pumps, enabling potential partnerships with insulin pump manufacturers and pen-injection ecosystems to expand distribution.

Early-stage growth With revenue in the low millions and a modest funding amount, PDT represents a lean, early-stage partner for strategic collaborations, pilot programs, and co-development with larger medical device and CGM ecosystem players.

Strategic collaboration fit The company’s technology complements major diabetes players and competitors listed, suggesting sales opportunities through OEM collaborations, distributor partnerships, and integration into existing CGM/insulin delivery platforms to accelerate market reach.